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One of the significant contributors to the variation of H/
M ratio in cardiac imaging, are the settings of the regions of
interest (ROIs) that are used. Currently, as correctly de-
scribed by Chen et al. [1, 2], there are three main approaches
ROI is placed along the anterior part of the LV wall [2].
In our current ongoing study in pediatric patients by van
der Palen et al.., we compared both approaches described by
Chen et al. (ie, the “whole heart ROI” and the “small
anterior wall ROI”). The reason for comparing those instead
of the “LV wall ROI” by Gerson et al. is twofold: possible
comparison of our results with Chen’s references and po-
tential inaccurate placement of an ROI along the complete
LV wall in small pediatric hearts (ie, the child’s heart is often
too small for exact placement over the LV wall). Several
studies in pediatric cardiology also use this approach [5, 6].
When studying the subsequently calculated H/M ratios
we noticed that the interobserver variability when using
these methods of ROI placement was only minor, when H/
M ratios were obtained independently by two observers at 4
and 24 h post injection in our population of 30 pediatric
patients. Intraclass correlation coefficients (ICCs) were as
follows: for the small anterior wall ROI H/M ratio 0.882
(95 % CI: 0.578–0.956) and for the whole heart ROI H/M
ratio 0.955 (95 % CI: 0.904–0.979) at 4 h. At 24 h, the ICC
was 0.911 (95 % CI: 0.716–0.965) for the small anterior
wall ROI H/M ratio and 0.951 (95 % CI: 0.896–0.977) for
the whole heart ROI H/M ratio. Therefore, it can be con-
cluded that the use of both ROI definition methods in
children results in substantial to almost perfect interobserver
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To the Editor:
With great interest we read the article by Chen et al. regard-
ing factors that affect heart-to-mediastinal ratio (H/M ratio)
in I-123 meta-iodobenzylguanidine (MIBG) cardiac sympa-
thetic imaging [1]. The authors describe the variation of H/
M ratio among institutions and the factors that contribute to
this. Furthermore, they provide different protocols that
could minimize this variation.
for drawing the heart ROI. One is to place the ROI over the
whole heart, thereby neglecting the “dilution” effect in
patients with a dilated heart (ie, lower blood pool activity
in the cavity than the myocardium) but resulting in high
reproducibility [1, 3]. The second approach is to place the
ROI along the left ventricular (LV) wall, inter alia described
by Gerson et al. [4], which possibly leads to greater inter-
and intraobserver bias [1]. In the third approach a smaller
agreement concerning H/M ratio. Furthermore, this suggests
that whole H/M ratio has better agreement than small H/M
ratio for both 4 and 24 h post injection scans.
Besides, both methods also showed a high within-patient
ICC ratio of 0.865. This implies that intrapatient variability is
fairly small and both methods give almost identical results.
Although the ICCs of both methods of ROI placement are
rather similar, the most promising method is the whole H/M
ratio 4 h post injection. To reduce differences in H/M ratios
due to interobserver variability the method of ROI placement
should be standardized, and it is reasonable to define this
method as the gold standard for H/M ratio measurement.
However, as stated in the article by Chen et al. [1], this
method could underestimate the H/M ratio in patients with a
dilated heart (being the target population in the article by
Chen et al.) and a relatively high negative contribution of
the myocardial cavity. This, however, has no impact on our
population, which does not contain patients with cardiomy-
opathy. Small anterior wall H/M ratios do not have this
disadvantage and showed adequate intraobserver agreement.
Therefore, we can conclude that the best method to
determinate the H/M ratio in cardiac sympathetic imaging
depends on the patient characteristics of the study group. In
pediatric patients we recommend the use of the whole heart
H/M ratio, since it shows the best intraobserver agreement.
With Chen we would like to emphasize the importance to
standardize ROI placement methods to compare study
results and minimize the intrapatient, interpatient, and inter-
institutional variation.
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